Search research articles
Contact Us
Filters
Showing results (41-50 of 331) with videos related to
Page
of 34
Sort By:
American Journal of Clinical Dermatology
|
June 23, 2022
Combination Therapy with Apremilast and Biologics for Psoriasis: A Systematic Review
Mette Gyldenløve, Farzad Alinaghi, Claus Zachariae, et al.
Chemistryopen
|
December 28, 2020
Pyridine-based Liquid-Phase Synthesis of Crystalline TiN and ZnSiN<sub>2</sub> Nanoparticles
Alexander Egeberg, Olivia Wenzel, Radian Popescu, et al.
Journal of Psoriasis and Psoriatic Arthritis
|
September 19, 2024
Adverse Events in Patients Receiving Placebo in Phase III Trials of Biologics for Psoriasis: A Systematic Review and Meta-Analysis
Gayathri Devaraj Ajenthen, Alexander Egeberg, Katrine Elsner Melgaard, et al.
Cutis
|
March 21, 2017
The role of biologic therapy for psoriasis in cardiovascular risk reduction
Daniel J No, Mina Amin, Alexander Egeberg, et al.
The Journal of Dermatological Treatment
|
May 8, 2018
Drug survival of secukinumab for psoriasis in a real-world setting
Erica B Lee, Mina Amin, Alexander Egeberg, et al.
Chemical Communications (Cambridge, England)
|
August 18, 2018
Pyridine-based low-temperature synthesis of CoN, Ni<sub>3</sub>N and Cu<sub>3</sub>N nanoparticles
Alexander Egeberg, Lucas Warmuth, Sven Riegsinger, et al.
Acta Dermato-Venereologica
|
May 4, 2016
Prognosis after Hospitalization for Erythroderma
Alexander Egeberg, Jacob P Thyssen, Gunnar H Gislason, et al.
The American Journal of Cardiology
|
July 4, 2016
Relation of Periodontitis to Risk of Cardiovascular and All-Cause Mortality (from a Danish Nationwide Cohort Study)
Gorm Mørk Hansen, Alexander Egeberg, Palle Holmstrup, et al.
American Journal of Clinical Dermatology
|
October 29, 2017
Choosing First-Line Biologic Treatment for Moderate-to-Severe Psoriasis: What Does the Evidence Say?
Mina Amin, Daniel J No, Alexander Egeberg, et al.
The Journal of Investigative Dermatology
|
August 22, 2018
Incidence and Risk of Inflammatory Bowel Disease in Patients with Psoriasis-A Nationwide 20-Year Cohort Study
Alexander Egeberg, Jacob P Thyssen, Johan Burisch, et al.
Page
of 34
Search research articles
Search
Showing results (41-50 of 331) with videos related to
Sort By:
Page
of 34
American Journal of Clinical Dermatology
|
June 23, 2022
Combination Therapy with Apremilast and Biologics for Psoriasis: A Systematic Review
Mette Gyldenløve, Farzad Alinaghi, Claus Zachariae, et al.
Chemistryopen
|
December 28, 2020
Pyridine-based Liquid-Phase Synthesis of Crystalline TiN and ZnSiN<sub>2</sub> Nanoparticles
Alexander Egeberg, Olivia Wenzel, Radian Popescu, et al.
Journal of Psoriasis and Psoriatic Arthritis
|
September 19, 2024
Adverse Events in Patients Receiving Placebo in Phase III Trials of Biologics for Psoriasis: A Systematic Review and Meta-Analysis
Gayathri Devaraj Ajenthen, Alexander Egeberg, Katrine Elsner Melgaard, et al.
Cutis
|
March 21, 2017
The role of biologic therapy for psoriasis in cardiovascular risk reduction
Daniel J No, Mina Amin, Alexander Egeberg, et al.
The Journal of Dermatological Treatment
|
May 8, 2018
Drug survival of secukinumab for psoriasis in a real-world setting
Erica B Lee, Mina Amin, Alexander Egeberg, et al.
Chemical Communications (Cambridge, England)
|
August 18, 2018
Pyridine-based low-temperature synthesis of CoN, Ni<sub>3</sub>N and Cu<sub>3</sub>N nanoparticles
Alexander Egeberg, Lucas Warmuth, Sven Riegsinger, et al.
Acta Dermato-Venereologica
|
May 4, 2016
Prognosis after Hospitalization for Erythroderma
Alexander Egeberg, Jacob P Thyssen, Gunnar H Gislason, et al.
The American Journal of Cardiology
|
July 4, 2016
Relation of Periodontitis to Risk of Cardiovascular and All-Cause Mortality (from a Danish Nationwide Cohort Study)
Gorm Mørk Hansen, Alexander Egeberg, Palle Holmstrup, et al.
American Journal of Clinical Dermatology
|
October 29, 2017
Choosing First-Line Biologic Treatment for Moderate-to-Severe Psoriasis: What Does the Evidence Say?
Mina Amin, Daniel J No, Alexander Egeberg, et al.
The Journal of Investigative Dermatology
|
August 22, 2018
Incidence and Risk of Inflammatory Bowel Disease in Patients with Psoriasis-A Nationwide 20-Year Cohort Study
Alexander Egeberg, Jacob P Thyssen, Johan Burisch, et al.
Page
of 34